Retour
76
Fourchette du Jour
33,40 €
35,99 €
Fourchette 52 Semaines
24,10 €
57,99 €
Volume
2 137 919
Moyenne 50J / 200J
45,69 €
/
39,68 €
Clôture Précédente
35,57 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -7,8 | 0,4 |
| P/B | 3,7 | 2,9 |
| ROE % | -40,2 | 3,7 |
| Net Margin % | -6046,2 | 3,8 |
| Rev Growth 5Y % | 63,5 | 10,0 |
| D/E | 0,1 | 0,2 |
Points Clés
Revenue grew 63,46% annually over 5 years — strong growth
Debt/Equity of 0,05 — conservative balance sheet
Negative free cash flow of -383,68M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 577,25%
Capital intensive — 74,87% of revenue goes to capex
Croissance
Revenue Growth (5Y)
63,46%
Revenue (1Y)640,71%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-40,17%
ROIC-37,24%
Net Margin-6046,22%
Op. Margin-6714,77%
Sécurité
Debt / Equity
0,05
Current Ratio12,32
Interest Coverage0,00
Valorisation
P/E Ratio
-7,81
P/B Ratio3,66
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 640,71% | Revenue Growth (3Y) | 38,48% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 63,46% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 7,70M | Net Income (TTM) | -465,32M |
| ROE | -40,17% | ROA | -40,98% |
| Gross Margin | 35,47% | Operating Margin | -6714,77% |
| Net Margin | -6046,22% | Free Cash Flow (TTM) | -383,68M |
| ROIC | -37,24% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,05 | Current Ratio | 12,32 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -7,81 | P/B Ratio | 3,66 |
| P/S Ratio | 472,23 | PEG Ratio | -0,28 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 3,63B | Enterprise Value | 3,58B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 7,70M | 1,04M | 4,01M | 4,74M | 1,08M |
| Net Income | -465,32M | -298,41M | -214,53M | -163,92M | -107,64M |
| EPS (Diluted) | -4,95 | -3,69 | -3,69 | -3,15 | -2,80 |
| Gross Profit | 2,73M | 1,04M | 4,01M | 4,74M | 1,08M |
| Operating Income | -516,77M | -338,85M | -222,61M | -167,88M | -107,70M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,14B | 1,43B | 635,35M | 352,18M | 351,02M |
| Total Liabilities | 143,41M | 109,79M | 96,25M | 35,85M | 19,07M |
| Shareholders' Equity | 992,08M | 1,32B | 539,11M | 316,33M | 331,94M |
| Total Debt | 48,54M | 51,72M | 51,73M | 3,08M | 3,07M |
| Cash & Equivalents | 101,54M | 264,55M | 54,90M | 32,67M | 200,70M |
| Current Assets | 1,05B | 1,38B | 574,15M | 345,18M | 344,72M |
| Current Liabilities | 85,07M | 59,68M | 43,94M | 27,72M | 16,00M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Capital Heavy Grower
#14 of 75
Activité Récente
Entré
Capital Heavy Grower
Mar 24, 2026